Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis and AIDS

F A Drobniewski1, A L Pozniak, A H Uttley

  • 1Regional Tuberculosis Centre, Dulwich Public Health Laboratory, King's College School of Medicine and Dentistry, London.

Journal of Medical Microbiology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Chronic conjunctivitis as an extragenital focus of genitourinary chlamydial infection].

Vestnik oftalmologii·2026
Same author

Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.

Medicine·2015
Same author

[Role of Chlamydia trachomatis intraocular infection in the development of proliferative vitreoretinopathy (experimental study)].

Vestnik oftalmologii·2015
Same author

Multidrug-resistant tuberculosis in the United Kingdom and Lithuania.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2014
Same author

[Dystrophic changes of vitreous in ocular chlamydia infection].

Vestnik oftalmologii·2013
Same author

[Role of Chlamydia trachomatis and Chlamydophila pneumoniae in damage of eye posterior segment structures].

Zhurnal mikrobiologii, epidemiologii i immunobiologii·2012

Tuberculosis (TB) cases are rising due to factors like HIV. TB in HIV-positive individuals presents unique challenges, including atypical symptoms and drug resistance, demanding new diagnostic and treatment approaches.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Global tuberculosis (TB) case decline has stalled or reversed since the mid-1980s.
  • Contributing factors include poverty, homelessness, immigration, inadequate TB control programs, and the rise of human immunodeficiency virus (HIV) infection.
  • TB in HIV-positive individuals presents atypical clinical and radiological features, often with lower sputum positivity and more rapid deterioration.

Purpose of the Study:

  • To review the clinical, microbiological, and epidemiological aspects of TB in HIV-infected individuals.
  • To highlight the challenges posed by atypical presentations and drug-resistant TB strains in this population.
  • To emphasize the need for improved diagnostic and therapeutic strategies.

Main Methods:

Related Experiment Videos

  • Literature review of clinical, microbiological, and epidemiological studies on TB in HIV-infected populations.
  • Analysis of diagnostic challenges, including atypical presentations and reduced sputum positivity.
  • Examination of treatment outcomes and the impact of multidrug-resistant TB (MDR-TB).
  • Main Results:

    • HIV-positive patients with TB exhibit atypical presentations, making diagnosis more difficult.
    • The emergence of MDR-TB, especially in HIV-coinfected individuals, leads to high mortality and has been linked to outbreaks.
    • Current diagnostic methods (microscopy and culture) require enhancement with more rapid techniques and novel drug susceptibility testing.

    Conclusions:

    • Effective TB management in HIV-infected individuals requires addressing atypical presentations and drug resistance.
    • There is a critical need for rapid diagnostic tools and new treatment regimens.
    • Prolonged, supervised treatment programs are essential for successful TB therapy in patients with Acquired Immunodeficiency Syndrome (AIDS).